Skip to Main Content
Menu Button
Ten Bridge Communications
LEARN ABOUT: nav-cta
Biotech’s communications partner

FOR TEN YEARS, WE HAVE BRIDGED...

Vision
To visibility
Progress
To partnerships
Vision
To impact

Learn about TBC's NewCo Studio

Learn More

Disrupting autoimmune disease. Precisely.

Merida Biosciences
View Story

A Bold Vision for RNA Editing

AIRNA
View Story

Making extraordinary medicines with Helicons

Parabilis Medicines
View Story

The AbC's of AI Antibody Drug Development

Archon Biosciences
View Story
Work
Team
Client News

Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy

Vividion Announces Publication in Science of Preclinical Data on Covalent Inhibitors of RAS-PI3K that Block Tumor Growth

Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies

SOTIO Strengthens Leadership Team with Appointments of Amy Jensen-Smith as Chief Scientific Officer and Ulrich Moebius as Chief Development Officer

AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer

Passion Growth Collaboration

Our team is deeply engaged with the biotech world, attuned to the latest developments and always looking around the corner to anticipate where the industry is moving.

Life At Ten Bridge
—>TOP